immunoregulatory progenitor cell therapy (Celixir)

N/A

Report date: 2025/03/20 15:07:51

Base Information

Drug Nameimmunoregulatory progenitor cell therapy (Celixir)
Drug Alias NameiRP stem cell therapy (Celixir)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cells modulatorsImmunomodulators
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCelixir
China Registration ClassN/A

Develop Information

Active CompaniesCelixir
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A